Yüklüyor......
A Phase I Combination Study of Trabectedin and Doxorubicin in Patients With Soft Tissue Sarcoma
PURPOSE: To determine the dose of trabectedin plus doxorubicin with granulocyte colony stimulating factor (G-CSF) support associated with manageable neutropenia and acceptable dose-limiting toxicities (DLTs) in patients with recurrent or persistent soft tissue sarcoma (STS). METHODS: In this phase I...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2008
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2777645/ https://ncbi.nlm.nih.gov/pubmed/18927308 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-0336 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|